Email ID
Password
Scrip   
Financing worries and rivals disrupted Pfizer's courting of Wyeth
01 April 2009
Christopher Spillane

The path towards Pfizer's $68 billion acquisition of Wyeth was littered with financing hurdles and the emergence of an unknown rival called "Company X", a regulatory filing has shown. Talks between the firms stalled continuously as the unravelling financial crisis crippled the debt markets.
Discussions...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36